Additionally, the review assesses the therapeutic potential of targeting EDA2R to mitigate inflammation, promote healthy ageing and treat conditions such as alopecia, sarcopenia, neurodegeneration and cardiovascular disease. Here, EDA2R is linked to sarcopenia.